Galera Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Galera Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Galera Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$4.21M, a 75% increase year-over-year.
  • Galera Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$27.4M, a 51.9% increase year-over-year.
  • Galera Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$49.3M, a 3.84% increase from 2022.
  • Galera Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$51.2M, a 30.2% increase from 2021.
  • Galera Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$73.4M, a 3.99% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$49.3M +$1.97M +3.84% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$51.2M +$22.1M +30.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$73.4M -$2.82M -3.99% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 -$70.6M -$19.9M -39.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$50.7M -$26.4M -109% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$24.3M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.